HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
Table 2
Positive predictive value of HCV RNA viral decline at week 2 after starting therapy for sustained virological response (on-treatment approach, N = 163).